LSTA
LSTA
NASDAQ · Biotechnology

Lisata Therapeutics Inc

$1.21
-0.07 (-5.47%)
Day Range $1.20 — $1.26
52W Range $0.96 — $5.07
Open$1.25
Previous Close$1.28
Day High$1.26
Day Low$1.20
52W High$5.07
52W Low$0.96
Volume—
Avg Volume177.4K
Market Cap13.40M
P/E Ratio—
EPS$-1.14
SectorBiotechnology

Analyst Ratings

Buy
9 analysts
6 Buy 3 Hold 0 Sell
Price Target +2,534.7% upside
Current
$1.21
Target
$31.88
$19.01 $31.88 avg $45.37

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 205.1K 969.5K 5.21M
Net Income -19,983,572 -84,996,289 -195,079
Profit Margin -9,756.5% -9,268.7% -3.8%
EBITDA -21,762,866 -97,706,629 -244,954
Free Cash Flow — — -167,798
Rev Growth -78.8% -78.8% -0.3%
Debt/Equity — — 1.55

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $469.15 +0.75% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $542.98 +0.81% 33.9 134.82B
REGN Regeneron Pharmaceuticals $959.96 +0.47% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $161.38 -2.22% 7.7 20.98B

LSTA News

No news for LSTA yet

Quick Stats

Market Cap13.40M
P/E Ratio—
EPS$-1.14
Volume—
SectorBiotechnology